Clinical trial Recruiting at 1 site Observational Ages 18 and up

Ultrasound-guided thermal ablation for benign thyroid nodules

Official title: Ultrasound-guided Thermal Ablation for the Treatment of Benign Thyroid Nodules: A Multicenter Study

Run by Chinese PLA General Hospital · NCT06729762 · Data updated 2026-11-12

This study tests whether a new ultrasound-guided heat treatment can safely shrink benign thyroid nodules and improve patients' experiences over a year.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorChinese PLA General Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedDecember 9, 2024
Main results expectedDecember 31, 2028
Study endsDecember 31, 2030
Registry record updatedFebruary 14, 2025
Trial IDNCT06729762 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with confirmed benign thyroid nodules who experience cosmetic or symptomatic issues and are not eligible for surgery.

Probably not a fit

Patients with malignant findings on biopsy or those with suspicious features on ultrasound will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the long-term outcomes of ultrasound-guided thermal ablation as a treatment for benign thyroid nodules. It is a multicenter observational study that aims to predict clinical outcomes based on patient experiences and follow-up data. Participants will undergo thermal ablation and will be monitored for at least 12 months to assess the effectiveness and safety of the procedure.

Why it matters

Potential benefit: If successful, this approach could provide a minimally invasive treatment option for patients with benign thyroid nodules, improving their quality of life.

How similar studies have gone: Other studies have shown promising results with ultrasound-guided thermal ablation for similar conditions, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. confirmation of benign nodule status on two separate fine- needle aspiration or core-needle biopsy
2. no suspicious malignant features on ultrasound examination
3. report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation
4. refusal or ineligibility for surgery
5. follow-up time ≥12 months

Exclusion Criteria:

1. follicular neoplasm or malignancy findings on biopsy
2. nodules with benign result on biopsy had suspicious of malignancy in US
3. patients with contra-lateral vocal cord paralysis
4. previous radiation to the head and neck
5. follow- up time less than 12 months

Where it's running

  • Chinese PLA General Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Yukun Luo — Chinese PLA General Hospital
  • Study coordinator: Lin Yan, MD
  • Email: gemma-y@163.com
  • Phone: 13811237313

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.